Comparison of Immunological Abnormalities of Lymphocytes in Bone Marrow in Myelodysplastic Syndrome (MDS) and Aplastic Anemia (AA)

被引:19
|
作者
Li, Xiao [1 ]
Xu, Feng [1 ]
He, Qi [1 ]
Wu, Lingyun [1 ]
Zhang, Zheng [1 ]
Chang, Chunkang [1 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Hosp 6, Dept Hematol, Shanghai, Peoples R China
关键词
myelodysplastic syndromes; aplastic anemia; lymphocytes; T cell subsets; polarization; ANTITHYMOCYTE GLOBULIN; T-CELLS; PATHOPHYSIOLOGY; HEMATOPOIESIS; REPERTOIRE; MANAGEMENT;
D O I
10.2169/internalmedicine.49.3477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The subsets and the polarization of lymphocytes in bone marrow from low-risk myelodysplastic syndrome (MDS) were studied and compared with those from patients with aplastic anemia (AA). Methods A total of 34 patients with low-risk MDS (IPSS score <= 1.0) who presented abnormal chromosomes and 16 patients with AA were enrolled in this study. We determined T lymphocyte subsets, T cells polarization status, and the percentages of NK cells and of B lymphocytes in bone marrow and compared these parameters between the two groups of patients. As controls, 24 patients with high-risk MDS (IPSS score>1.0) presenting abnormal chromosomes and 22 healthy/benign hematologic disease subjects were used. Results In low-risk MDS/AA patients, the percentage of CD3+ lymphocytes was significantly increased compared to controls (p=0.006 and p=0.001), while the percentage of CD19+ lymphocytes was significantly decreased (p<0.001 and p=0.002); there were no significant differences between MDS/AA and normal controls in other parameters; For low-risk MDS patients, the polarization status of bone marrow CD4+ cells toward Th1 (Th1/Th2) and of CD8+ cells toward Tc1 (Tc1/Tc2) was stronger than that for AA patients (p=0.05 and p<0.001). Other parameters did not show significant differences; Regardless of the predominance of CD4 or CD8 T cells, all patients with low-risk MDS were accompanied with elevated Tc1 polarization (Tc1/Tc2). Conclusion In both AA and MDS, the number of total T lymphocytes increased. However, polarization towards Th1 and Tc1 was obviously stronger in MDS patients than in AA patients. This might be related to T cell stimulation from the clones of malignant hematopoietic cells.
引用
收藏
页码:1349 / 1355
页数:7
相关论文
共 50 条
  • [1] Determinants of late infection following marrow transplantation (MT) for aplastic anemia (AA) and myelodysplastic syndrome (MDS).
    Sullivan, KM
    Nims, J
    Leisenring, W
    Flowers, M
    Bowden, R
    Anasetti, C
    Deeg, HJ
    Anderson, J
    Appelbaum, FR
    Storb, R
    BLOOD, 1995, 86 (10) : 841 - 841
  • [2] Myelodysplastic Syndrome (MDS)-Determining Clonal Events at Presentation of Aplastic Anemia (AA)
    Negoro, Eiju
    Hosono, Naoko
    Shen, Wenyi
    Yoshizato, Tetsuichi
    Patel, Bhumika J.
    Hirsh, Cassandra
    Przychodzen, Bartlomiej
    Clemente, Michael J.
    Mahfouz, Reda Z.
    Wodnar-Filipowicz, Aleksandra
    Makishima, Hideki
    Ogawa, Seishi
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    BLOOD, 2015, 126 (23)
  • [3] Abnormalities of the bone marrow (BM) microenvironment in the myelodysplastic syndrome (MDS).
    Silverman, LR
    Zinzar, S
    Cuttner, J
    Holland, JF
    BLOOD, 1995, 86 (10) : 3194 - 3194
  • [4] Bone tissue and bone marrow failure (aplastic anaemia (AA)) and hypoplastic myelodysplastic syndrome
    Ponomarenko, VM
    Rugal, VI
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 873 - 873
  • [5] Bone marrow cytogenetic abnormalities of aplastic anemia
    Keung, YK
    Pettenati, MJ
    Cruz, JM
    Powell, BL
    Woodruff, RD
    Buss, DH
    AMERICAN JOURNAL OF HEMATOLOGY, 2001, 66 (03) : 167 - 171
  • [6] Hemogram and bone marrow morphology in children with chronic aplastic anemia and myelodysplastic syndrome
    Wen, Jin-Quan
    Feng, Hai-Lin
    Wang, Xu-Qing
    Pang, Ju-Ping
    WORLD JOURNAL OF PEDIATRICS, 2008, 4 (01) : 36 - 40
  • [7] Hemogram and bone marrow morphology in children with chronic aplastic anemia and myelodysplastic syndrome
    Jin-Quan Wen
    Hai-Lin Feng
    Xu-Qing Wang
    Ju-Ping Pang
    World Journal of Pediatrics, 2008, 4 : 36 - 40
  • [8] Alemtuzumab treatment for aplastic anemia (AA) and low-risk myelodysplastic syndrome (MDS): Preliminary results
    Lee, Je-Hwan
    Choi, Seong-Jun
    Lee, Jung-Hee
    Seol, Miee
    Lee, Young-Shin
    Sim, Soo-Yung
    Ryu, Seong-Gil
    Kang, Young-Ah
    Lee, Kyoo-Hyung
    BLOOD, 2007, 110 (11) : 438A - 438A
  • [9] Pancytopenia and hypocellular bone marrow with multiple complex karyotypic abnormalities: Aplastic anemia vs hypoplastic myelodysplastic syndrome.
    Woytowitz, DV
    Humphries, JE
    BLOOD, 1995, 86 (10) : 3211 - 3211
  • [10] Significance of HLA-DR15 haplotype in Japanese patients with aplastic anemia (AA) or myelodysplastic syndrome (MDS).
    Andoh, S
    Tsunoda, Y
    Okamoto, M
    Maruyama, Y
    Shichishima, T
    BLOOD, 2002, 100 (11) : 232A - 232A